![](/img/cover-not-exists.png)
A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: An analysis of the ATHENA trial
Llombart-Cussac, Antonio, Pivot, Xavier, Biganzoli, Laura, Cortes-Funes, Hernan, Pritchard, Kathleen I., Pierga, Jean-Yves, Smith, Ian, Thomssen, Christoph, Srock, Stefanie, Sampayo, Miguel, Cortes, JVolume:
23
Language:
english
Journal:
The Breast
DOI:
10.1016/j.breast.2014.06.017
Date:
October, 2014
File:
PDF, 725 KB
english, 2014